Neuroimmunology Program - IDIBAPS

Team

Back

Elena H Martínez-Lapiscina

Director of the Visual-Pathway Lab. Neurologist MD PhD at Hospital Clinic of Barcelona. Junior principal investigator at IDIBAPS, Barcelona, Spain.

Dr. Elena H. Martínez-Lapiscina is a Neurologist PhD at the Hospital Clinic and junior PI of the Visual Pathway Lab at The Institut d´Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). She treats adults with multiple sclerosis and other immune-mediated disorders of the central nervous system. Her research revolves around multimodal assessment of the afferent visual pathway and their potential roles to elucidate mechanisms relationships between inflammation, demyelination and neurodegeneration in multiple sclerosis, neuromyelitis optica spectrums disorders and acute optic neuritis and to develop markers for monitoring prognosis and therapy response for these disorders. She is also interested in furthering knowledge and development of markers for Parkinson´s disease, Alzheimer´s disease and other CNS disorders.

Elena H. Martínez-Lapiscina was born in 1982 in Vitoria-Gasteiz, Spain. She earned he MD at University of Navarra School of Medicine in Pamplona, Spain in 2006. She won a Special Mention at the National Spanish Medical Degree Award Commission (2005-2006) by the Ministry of Education and Science, Spain [GPA=3.99/4.00 certified by WES]. After obtained the number 1 out of approximately 12,000 candidates in the Spanish MIR examen (the Spanish analogue to the USMLE) in the 2007 call, she completed her training in neurology in 2012 at Complejo Hospitalario de Navarra, Pamplona Spain. In 2013, Elena H Martínez-Lapiscina received her PhD in Cognition and Neurosciences with a project based on the effects of healthy eating on cognitive function (advisor Prof. Dr. Martínez-González and Dr. Clavero, maximum Calification Cum Laude). In 2012, she incorporated to the Visual Pathway Lab section of the Villoslada´s pathogenesis and new therapies lab at IDIBAPS. Since 2012, she has published 32 articles including 18 articles in the Q1 (11/18 D1), 6 chapters and earned 3 projects as PI (two national and one international).